Cofactor Genomics to Provide Solid Tumor Immune Profiling for Genocea Biosciences
— Pilot study to evaluate use of Cofactor assay in Genocea’s neoantigen vaccine clinical trial —December 04, 2018 09:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Cofactor Genomics, a clinical RNA sequencing and translational assay developer, today announced a pilot study to evaluate use of Cofactor’s ImmunoPrismTM assay in Genocea Biosciences’ Phase 1/2a clinical trial testing the... Read more